Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Alami, A. Krewski, D. Farhat, N. Mattison, D. Wilson, K. Gravel, C. A. Farrell, P. J. Crispo, J. A. G. Haddad, N. Perez-Lloret, S. Villeneuve, P. J.

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Torella, M. Marrapodi, M. M. Ronsini, C. Ruffolo, A. F. Braga, A. Frigerio, M. Amabile, E. Vastarella, M. G. Rossi, F. Riemma, G.

Risk of Premature Ovarian Insufficiency after Human Papilloma Virus Vaccination: A PRISMA Systematic Review and Meta-Analysis of Current Evidence

  • Adolescents
  • Human papillomavirus (HPV)
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Abutaleb, M. H. Makeen, H. A. Meraya, A. M. Alqahtani, S. S. Al-Mass, B. I. Aljazaeri, R. O. Alhazmi, B. D. Kalakattawi, A. M. N. Alajam, A. A.

Risks of Cardiac Arrhythmia Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Arabi, M. Al-Najjar, Y. Sharma, O. Kamal, I. Javed, A. Gohil, H. S. Paul, P. Al-Khalifa, A. M. Laws, S. Zakaria, D.

Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Clark, L. R. Johnson, D. R.

Safety and Clinical Benefits of Adacel® and Adacel®-Polio Vaccination in Pregnancy: A Structured Literature Review

  • Pregnant women
  • Pertussis
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Piechotta, V. Siemens, W. Thielemann, I. Toews, M. Koch, J. Vygen-Bonnet, S. Kothari, K. Grummich, K. Braun, C. Kapp, P. Labonté, V. Wichmann, O. Meerpohl, J. J. Harder, T.

Safety and effectiveness of vaccines against COVID-19 in children aged 5-11 years: a systematic review and meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2023 ∙ Mengstu, S. Beyene Berha, A.

Safety and Efficacy of COVID-19 Vaccine in Africa: Systematic Review

  • Africa
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Malone, Shelia M. Mitra, Amal K. Onumah, Nwanne A. Brown, Alexis Jones, Lena M. Tresvant, Da'Chirion Brown, Cagney S. Onyia, Austine U. Iseguede, Faith O.

Safety and Efficacy of Post-Eradication Smallpox Vaccine as an Mpox Vaccine: A Systematic Review with Meta-Analysis

  • Adults
  • Mpox
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wilson, Lydia Gracie, Lara Kidy, Farah Thomas, G. Neil Nirantharakumar, Krishnarajah Greenfield, Sheila Manaseki-Holland, Semira Ward, Derek J. Gooden, Tiffany E.

Safety and efficacy of tuberculosis vaccine candidates in low- and middle-income countries: a systematic review of randomised controlled clinical trials

  • Newborn
  • Adolescents
  • Adults
  • Low and Middle Income Countries
  • Tuberculosis
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Hu, Y. Wang, Y. Shao, T. Tang, W. Hu, K. Zhou, Y. Miao, L. Liu, J. Wang, B. Yu, W.

Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...